Severe Bradycardia Leading to Hemodynamic Instability Associated with Remdesivir Use in a Patient with COVID-19 Pneumonia

Severe Bradycardia Leading to Hemodynamic Instability Associated with Remdesivir Use in a Patient with COVID-19 Pneumonia

Remdesivir (RDV) is an approved treatment for hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. There is limited literature on the cardiac adverse effects of RDV. We report a case of a patient who developed hemodynamically unstable bradycardia after t...

Full description

Bibliographic Details
Main Authors: Bhargavi Donepudi, Shikhar Agarwal, Lokendra Thakur
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Case Reports in Critical Care
Online Access:http://dx.doi.org/10.1155/2022/8807957

Similar Items

Similar Items